BSE filing, NSE: CENPORT. Summary written from the filing by ALFA Finder's alert engine.
Arunjyoti Bio Ventures Ltd: key numbers
- Share price
- ₹3.92
- Market cap
- ₹73.06 Cr
- Revenue (annual)
- ₹27.75 Cr
- Net profit (annual)
- ₹-4.54 Cr
- P/E (TTM)
- -12.2×Sector 43.1×
- Promoter holding
- 47.64%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Arunjyoti Bio Ventures Ltd
All →Arunjyoti Bio Ventures Other Announcement
The company submitted its quarterly shareholding pattern for the period ending September 30, 2026, as per regulatory requirements.
Arunjyoti Bio Ventures Other Announcement
Pasura Industries Limited is shifting its registered office within Hyderabad, effective November 1, 2026. This administrative change was approved by the Board via circular resolution.
Arunjyoti Bio Ventures Annual General Meeting
Arunjyoti Bio Ventures Ltd held its 40th Annual General Meeting on August 12, 2026, via video conference. The company disclosed proceedings of the meeting.
Arunjyoti Bio Ventures Annual General Meeting
Arunjyoti Bio Ventures Ltd. will hold its 40th Annual General Meeting on August 12, 2026, to conduct ordinary business and approve the appointment of secretarial auditors.
Arunjyoti Bio Ventures Other Announcement
Arunjyoti Bio Ventures Ltd has filed its quarterly shareholding pattern for the period ending June 30, 2026, in compliance with SEBI regulations.
Arunjyoti Bio Ventures Management Change
Arunjyoti Bio Ventures appointed M/s. Vivek Surana & Associates as Secretarial Auditor for five years. This follows the resignation of M/s. Manoj Parakh & Associates.
- Execution
- 60 months
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.